171 related articles for article (PubMed ID: 35488236)
1. LMOD1, an oncogene associated with Lauren classification, regulates the metastasis of gastric cancer cells through the FAK-AKT/mTOR pathway.
Tan Y; Chen Q; Pan S; An W; Xu H; Xing Y; Zhang J
BMC Cancer; 2022 Apr; 22(1):474. PubMed ID: 35488236
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein C-II induces EMT to promote gastric cancer peritoneal metastasis via PI3K/AKT/mTOR pathway.
Wang C; Yang Z; Xu E; Shen X; Wang X; Li Z; Yu H; Chen K; Hu Q; Xia X; Liu S; Guan W
Clin Transl Med; 2021 Aug; 11(8):e522. PubMed ID: 34459127
[TBL] [Abstract][Full Text] [Related]
3. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
[TBL] [Abstract][Full Text] [Related]
4. MAOA suppresses the growth of gastric cancer by interacting with NDRG1 and regulating the Warburg effect through the PI3K/AKT/mTOR pathway.
Wang YY; Zhou YQ; Xie JX; Zhang X; Wang SC; Li Q; Hu LP; Jiang SH; Yi SQ; Xu J; Cao H; Zhao EH; Li J
Cell Oncol (Dordr); 2023 Oct; 46(5):1429-1444. PubMed ID: 37249744
[TBL] [Abstract][Full Text] [Related]
5. E2F2 inhibition induces autophagy via the PI3K/Akt/mTOR pathway in gastric cancer.
Li H; Zhao S; Shen L; Wang P; Liu S; Ma Y; Liang Z; Wang G; Lv J; Qiu W
Aging (Albany NY); 2021 Apr; 13(10):13626-13643. PubMed ID: 34091441
[TBL] [Abstract][Full Text] [Related]
6.
Qian Y; Yan Y; Lu H; Zhou T; Lv M; Fang C; Hou J; Li W; Chen X; Sun H; Li Y; Wang Z; Zhao N; Gu Y; Ding Y; Liu Y
Anticancer Agents Med Chem; 2019; 19(14):1754-1761. PubMed ID: 31364518
[TBL] [Abstract][Full Text] [Related]
7. DDR2 Induces Gastric Cancer Cell Activities via Activating mTORC2 Signaling and Is Associated with Clinicopathological Characteristics of Gastric Cancer.
Wang YG; Xu L; Jia RR; Wu Q; Wang T; Wei J; Ma JL; Shi M; Li ZS
Dig Dis Sci; 2016 Aug; 61(8):2272-2283. PubMed ID: 27010547
[TBL] [Abstract][Full Text] [Related]
8. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.
Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S
Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766
[TBL] [Abstract][Full Text] [Related]
9. Deregulation of MicroRNA-375 Inhibits Proliferation and Migration in Gastric Cancer in Association With Autophagy-Mediated AKT/mTOR Signaling Pathways.
Yuan KT; Li BX; Yuan YJ; Tan M; Tan JF; Dai WG; Feng WD; Zuo JD
Technol Cancer Res Treat; 2018 Jan; 17():1533033818806499. PubMed ID: 30355273
[TBL] [Abstract][Full Text] [Related]
10. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
[TBL] [Abstract][Full Text] [Related]
11. Baicalein Inhibits Gastric Cancer Cell Proliferation and Migration through a FAK Interaction via AKT/mTOR Signaling.
Qiao D; Jin J; Xing J; Zhang Y; Jia N; Ren X; Lin Z; Jin N; Chen L; Piao Y
Am J Chin Med; 2021; 49(2):525-541. PubMed ID: 33641654
[TBL] [Abstract][Full Text] [Related]
12. Ox-LDL-mediated ILF3 overexpression in gastric cancer progression by activating the PI3K/AKT/mTOR signaling pathway.
Sun D; Zhang M; Wei M; Wang Z; Qiao W; Liu P; Zhong X; Liang Y; Chen Y; Huang Y; Yu W
Aging (Albany NY); 2022 May; 14(9):3887-3909. PubMed ID: 35507914
[TBL] [Abstract][Full Text] [Related]
13. The molecular mechanism of baicalein repressing progression of gastric cancer mediating miR-7/FAK/AKT signaling pathway.
Qiao D; Xing J; Duan Y; Wang S; Yao G; Zhang S; Jin J; Lin Z; Chen L; Piao Y
Phytomedicine; 2022 Jun; 100():154046. PubMed ID: 35306368
[TBL] [Abstract][Full Text] [Related]
14. Effects of β-carboline alkaloids from Peganum harmala on the FAK/PI3K/AKT/Mtor pathway in human gastric cancer cell line SGC-7901 and tumor-bearing mice.
Fan Y; Zeng F; Ma L; Zhang H
Pak J Pharm Sci; 2021 May; 34(3):891-898. PubMed ID: 34602411
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of TYRO3 indicates poor prognosis and induces gastric cancer progression via AKT-mTOR pathway.
Wang J; Cheng Z; Dai D; Li H; Shao X; Xu M
Mol Carcinog; 2023 Sep; 62(9):1325-1337. PubMed ID: 37212497
[TBL] [Abstract][Full Text] [Related]
16. Significant association of DIRC1 overexpression with tumor progression and poor prognosis in gastric cancer.
Li Z; Yang AJ; Wei FM; Zhao XH; Shao ZY
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8682-8689. PubMed ID: 30575946
[TBL] [Abstract][Full Text] [Related]
17. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer.
Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P
Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253
[TBL] [Abstract][Full Text] [Related]
18. Super-enhancer-associated EEPD1 facilitates EMT-mediated metastasis by regulating the PI3K/AKT/mTOR pathway in gastric cancer.
Jin Y; Xia Y; Du H; Xiang T; Lan B; Wei S; Li H; Huang H
Biochem Biophys Res Commun; 2023 Dec; 689():149188. PubMed ID: 37976838
[TBL] [Abstract][Full Text] [Related]
19. Sinulariolide Inhibits Gastric Cancer Cell Migration and Invasion through Downregulation of the EMT Process and Suppression of FAK/PI3K/AKT/mTOR and MAPKs Signaling Pathways.
Wu YJ; Lin SH; Din ZH; Su JH; Liu CI
Mar Drugs; 2019 Nov; 17(12):. PubMed ID: 31783709
[TBL] [Abstract][Full Text] [Related]
20. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
